Browse > Article

Apolipopretein A-I and B Distribution among the Employees and their Partners in Korea  

Kim, Won-Sool (Department of Occupational Medicine, College of Medicine, Sungkyunkwan University)
Kim, Dong-Il (Department of Occupational Medicine, College of Medicine, Sungkyunkwan University)
Suh, Byung-Sung (Department of Occupational Medicine, College of Medicine, Sungkyunkwan University)
Publication Information
Journal of Preventive Medicine and Public Health / v.40, no.1, 2007 , pp. 71-76 More about this Journal
Abstract
Objectives : This study was performed to investigate the distribution of apolipoproteins A-I and B among Korean employees and their partners. Methods : The study population consisted of 7,633 men and women (4,578 men and 3,054 women) residing in Seoul and Kyung-gee Do, with an average age of $43.5{\pm}8.3$ years. Blood samples were collected following at least 12 hours of fasting. Apolipoproteins A-I and B were measured using a Behring Nephelometer analyzer. The body mass index (BMI) for each participant was calculated as weight (kg) divided by height squared $(m^2)$. Information on health-related behaviors such as exercise, alcohol intake, and smoking habits was collected through self-administrated questionnaires. Results : The mean concentrations of Apo A-I were $132.6{\pm}22.3mg/dL$ and $142.9{\pm}24.8mg/dL$ in the men and women, respectively. The concentration of Apo A-I increased significantly across all age categories of men. The mean concentrations of Apo B were $101.7{\pm}23.2mg/dL$ and $87.8{\pm}23.5mg/dL$ in the men and women, respectively, and Apo B increased significantly across all age categories for both the men and women. Exercise and BMI were major determinants for Apo A-I and B levels. The 10th percentile of Apo A-I concentration was 109 mg/dL in the men and 113 mg/dL in the women, and the 90th percentile of Apo B concentration was 131 mg/dL in the men and 118 mg/dL women. Conclusions : For the prevention of coronary artery disease, we recommend that for individuals in the 10th percentile of concentration for Apo A-I and the 90th percentile of concentration for Apo B, active preventive interventions such as weight loss and exercise should be taken. This study, within its limitations, may be useful for evaluating apolipoprotein A-I and B concentrations in Korean adults.
Keywords
Apolipoprotein A-I; Apolipoprotein B;
Citations & Related Records

Times Cited By SCOPUS : 1
연도 인용수 순위
1 Talmud PJ, Hawe E, Miller GJ, Humphries SE. Non fasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol 2002; 22(11): 1918-1923   DOI   ScienceOn
2 Marcovina SM, Albers JJ, Dati F. International federation of clinical chemistry standardization project for measurement of apolipoproteins A-I and B. Clin Chem 1991; 37(10 Pt1): 1676- 1682   PUBMED
3 Victoria Valles, Carlos A, Aguilar-Salinas, Francisco J, Gomez-Perez, Rosalba Rojas, Aurora Franco, Gustavo Olaiz, Juan A, Rull, Jaime Sepulveda. Apolipoprotein B and A-I distribution in Mexican urban adults : Results of a nationwide survey. Metabolism 2002; 51(5): 560-568   DOI   ScienceOn
4 Graziani MS, Zanolla L, Righetti G. Plasma apolipoprotein A-I and B in survivors of myocardial infarction and in a control group. Clin Chem 1998; 44(1): 134-140   PUBMED
5 Durrington PN, Bolton CH, Hartog M. Serum and lipoprotein apolipoprotein B levels in normal subjects and patients with hyperlipoproteinemia. Clin Chim Acta 1978; 82(1-2): 151-160   DOI   PUBMED   ScienceOn
6 Bhopal R, Unwin N, White M, Yallop J, Walwer L, Alberti, Harland J, Patel S, Asmad N, Turner C, Watson B, Kaur D, Kulkarni A, Laker M, Tavridou A. : Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations : Cross sectional study. BMJ 1999; 319(7204): 215-220   DOI   PUBMED   ScienceOn
7 Fodor JG, Frohlich JJ. Recommendations for the management and treatment of dyslipidemia. Report of the working group on hypercholesterolemia and other dyslipidemias. CMAJ 2000; 162(10): 1441-1447   PUBMED
8 British Cardiac Society, British Hyperlipidemia Association, British Hypertension Society, British Diabetic Association: Joint British recommendations on prevention of coronary heart disease in clinical pratice:summary. BMJ 2000; 320(7236): 705-708   DOI   PUBMED   ScienceOn
9 Wallius G, Jungner I, Holme I, Aastveit AH, Kolar W, Steiner E, High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infaction (AMORIS study); A prospective study. Lancet 2001; 358(9298); 2026-2033   DOI   ScienceOn
10 Karpe F, Bell M, Bjorkegren J. Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl palmitate ester labelling and simulataneous measurements of apolipoprotein B-48 and B-100. Arterioscler Thromb 1995; 15(2): 199-207   DOI   ScienceOn
11 Bachorik P, Lovejoy K, Carroll M. Apolipoprotein B and AI distribution in the United States, 1988-1991 : Results of the national health and nutrition examination survey III (NHANES III). Clin Chem 1997; 43(12): 2364-2378
12 Contosis J, McNamara J, Lammi-Keefe C. Reference intervals for plasma apolipoprotein B determined with a standardized commercial immunoturbidimetric assay : Resukts from the Framingham offspring study. Clin Chem 1996; 42(4): 515-523   PUBMED
13 Rosseneu M, Fruchart JC, Bard JM. Plasma apolipoprotein concentrations in young adults with a parental history of premature coronary heart disease and in control subjects. The EARS study. Circulation 1994; 89(5): 1967- 1973   DOI   PUBMED   ScienceOn
14 Evans K, Laker MF. Intra-individual factors affecting lipid, lipoprotein and apolipoprotein measurement : A review. Ann Clin Biochem 1995; 32(Pt 3): 261-280   DOI   PUBMED
15 Dixon LB, Sudquist J, Kinkleby M. Differences in energy, nutrition and food intakes in a US sample of Mexican American women and men : Finding from the third national health and nutrition examination survey, 1988-1994. Am I Epidemiol 2000; 152(6): 548-557
16 Laker MF, Evans K. Anlysis of apolipoprotein. Ann Clin. Biochem 1996; 33(Pt1): 5-22
17 Ballantyne C, Grundy SM, Oberman A. Hyperlipidemia : Diagnostic and therapeutic perspectives. J Clin Endocrinol Metab 2000; 85(6): 2089-2112   DOI   ScienceOn
18 Bhatnagar D, Durrington P. Measurement and Clinical Significance of Apolipoprotein A-I and B, in Rifai N, Warnick GR, Dominiczak M (eds): Handbook of Lipoprotein Testing. Washington, DC, AACC, 1997. pp 177-198
19 Colvin P, Parks J. Metabolism of high density lipoprotein subfractions. Curr Opin Lipidol 1999; 10(4): 309-314   DOI   ScienceOn
20 Sniderman AD, Wolfson C, Teng B. Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and athersclerosis. Ann Intern Med 1982; 97(6) : 833-839   DOI   PUBMED   ScienceOn
21 Jungner I, Marcovina S, Walldius G. Apolipoprotein B and A-I values 1n 147,576 Swedish males and female, standardized according to the World Health Organizationinternational federation of clinical chemistry first international reference materials. Clin Chem 1998; 44(8 Pt1): 1641-1649   PUBMED
22 Sniderman A, Cianflone K. Measurement of apoproteins : Time to improve the diagnosis and treatment of atherrogenic dyslipoproteinemias. Clin Chem 1996; 42(4): 489-491   PUBMED
23 Leino A, Impivaara O, Kaitaari M, Jarvisalo J. Serum concentrations of apolipoprotein A-I, apolipoprotein B and lipoprotein (a) in a finnish sample. Clin Chem 1995; 41(11): 1633-1636   PUBMED
24 Assmann G, Schulte H. Results and Conclusions of the Prospective Cardiovascular Munster (PROCAM) Study, in Assmann G (ed): Lipid Metabolism Disorders and Coronary Heart Disease. Munich, Germany, MMV Medizin Verlag, 1993. pp 21-67
25 Rahmani M, Raiszadeh F, Allaheverdian S, Kiaii S, Navab M, Azizi F. Coronary artery disease is associated with the ratio of apolipoprotein A-I/B and serum concentration of apolipoprotein B, but not with paraoxanase enzyme activity in Iranian subjects. Atherosclerosis 2002; 162(2): 381-389   DOI   ScienceOn
26 Lamarche B, Moorjani S, Lupien PJ. Apolipoprotein AI and B concentrations and the risk of ischemic heart disease during a 5 year follow up of men in the Quebec cardiovascular study. Circulation 1996; 94(3): 273-278   DOI   PUBMED   ScienceOn